Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vascular disease
Research
Custom gene editor fixes mutation causing deadly disease in mice
Swapping out a mutant letter in the ACTA2 gene saved the lives of mice with an ultrarare vascular disease, while all untreated mice died.
Darren Incorvaia
Sep 11, 2025 1:48pm
How a nanomedicine could treat complications of vascular disease
Dec 9, 2021 3:30pm
Abbott builds out endovascular offerings with Walk Vascular buy
Sep 2, 2021 12:18pm
Avicenna's pulmonary-embolism-spotting AI OKed in U.S., EU
Jun 2, 2021 10:15am
AdComm experts split on whether to OK ChemoCentryx's avacopan
May 7, 2021 6:47am
ChemoCentryx's stock sinks as FDA flags issues with pivotal data
May 5, 2021 8:25am